Herpes Zoster Viral (HZV) infection after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: a case series.

2021
We report the first cases of Varicella Zoster Viral (VZV) infection after AZD1222 and BNT162b2 COVID-19 mRNA vaccines in Greece. As the World Health Organization ( WHO) declared the coronavirus disease-2019 (COVID-19) as a pandemic, the production for a safe and effective vaccine COVID-19 became a global priority. 1 In December 2020, the European Medicines Agency (EMA) first approved the BNT162b2 (Pfizer-BioNTech COVID-19 mRNA) vaccine and the AZD1222 (Oxford/AstraZeneca COVID-19) vaccine. 2.
    • Correction
    • Source
    • Cite
    • Save
    10
    References
    0
    Citations
    NaN
    KQI
    []
    Baidu
    map